**1. Introduction**

102 Breast Cancer – Focusing Tumor Microenvironment, Stem Cells and Metastasis

Welshons, WV.; Thayer, KA.; Judy, BM.; Taylor, JA.; Curran, EM. & Vom Saal, FS. (2003).

Yokochi, T. & Gilbert. DM. (2007). Replication labeling with halogenated thymidine analogs.

Zarghi, A.; Zebardast, T.; Hakimion, F.; Shirazi, F.H.; Rao, P.N. & Knaus, E.E. (2006).

Zhu, Y.; Sullivan, LL.; Nair, SS.; Williams, CC.; Pandey, A.; Marrero, L.; Vadlamudi, RK. &

*Curr Protoc Cell Biol*., Chapter.22, Unit.22.10

*Cancer Res*. Vol.66, No.16, pp. 7991–7998

inhibitors. *Bioorg Med Chem*. Vol.14, No.20, pp. 7044-7050

1006.

Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. *Environ Health Perspect*. Vol.111, No.8, pp. 994-

Synthesis and biological evaluation of 1,3-diphenylprop-2-en-1-ones possessing a methanesulfonamido or an azido pharmacophore as cyclooxygenase-1/-2

Jones, FE. (2006). Coregulation of estrogen receptor by estrogen-inducible ERBB4/HER4 establishes a growth promoting autocrine signal in breast cancer.
